Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.
暂无分享,去创建一个
B J Hoffer | R Freedman | Richard S. J. Frackowiak | K L Leenders | A. Björklund | O. Lindvall | R. Frackowiak | J. Rothwell | S. Rehncrona | L. Olson | I. Strömberg | B. Gustavii | B. Hoffer | R. Freedman | P. Brundin | G. Steg | K. Leenders | H. Widner | M. Bygdeman | H Widner | L Olson | O Lindvall | J C Rothwell | S Rehncrona | B Astedt | A Björklund | B. Johnels | A. Seiger | P Brundin | R Frackowiak | A Seiger | B Johnels | G Steg | I Strömberg | B Gustavii | T Lindholm | D Marsden | M Bygdeman | B. Åstedt | T. Lindholm | D. Marsden
[1] R. Bakay,et al. Biochemical and Behavioral Correction of MPTP Parkinson‐like Syndrome by Fetal Cell Transplantation a , 1987, Annals of the New York Academy of Sciences.
[2] R. Roth,et al. Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. , 1988, Progress in brain research.
[3] A. Björklund,et al. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis , 1987, Neuroscience.
[4] Frances K. Graham,et al. Memory-for-Designs Test: Revised General Manual , 1960 .
[5] W. Freed,et al. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long‐term behavioral, biochemical, and histochemical studies , 1980, Annals of neurology.
[6] D. Graham,et al. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.
[7] C. Marsden,et al. Disturbance of sequential movements in patients with Parkinson's disease. , 1987, Brain : a journal of neurology.
[8] G. Gerhardt,et al. Intracerebral xenografts of human mesencephalic tissue into athymic rats: immunochemical and in vivo electrochemical studies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[9] L. Olson,et al. Substantia nigra transplants into denervated striatum of the rat: Ultrastructure of graft and host interconnections , 1985, The Journal of comparative neurology.
[10] Y. Agid,et al. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.
[11] R. Bakay,et al. Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. , 1985, Applied neurophysiology.
[12] C Nahmias,et al. Cerebral Metabolism of 6–[18F]Fluoro‐l‐3,4‐Dihydroxyphenylalanine in the Primate , 1987, Journal of neurochemistry.
[13] T Jones,et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[14] G. Sedvall,et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. , 1985, Journal of neurosurgery.
[15] L. Olson,et al. Reinnervation of dopamine-denervated striatum by substantia nigra transplants: Immunohistochemical and electrophysiological correlates , 1985, Neuroscience.
[16] Coons Ah. Fluorescent antibody methods , 1968 .
[17] Forno Ls,et al. The Lewy body in Parkinson's disease. , 1987 .
[18] G. Arbuthnott,et al. Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain , 1985, Neuroscience Letters.
[19] M. Moal,et al. Activation of striatal dopaminergic grafts by haloperidol , 1985, Brain Research Bulletin.
[20] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[21] G. Rose,et al. Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: An in vivo electrochemical study , 1985, Brain Research.
[22] E. Möller,et al. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience. , 1988, Transplantation proceedings.
[23] R. Duvoisin,et al. Speculations on the etiology of Parkinson's disease. , 1984, Advances in neurology.
[24] A. Granholm,et al. Human fetal mesencephalic tissue grafted to dopamine-denervated striatum of athymic rats: light- and electron-microscopical histochemistry and in vivo chronoamperometric studies , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] A. Bjo¨rklund,et al. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.
[26] E. Melamed. Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease. , 1986, Archives of neurology.
[27] A. Bjo¨rklund,et al. Transplantation of central and peripheral monoamine neurons to the adult rat brain: Techniques and conditions for survival , 1976, Brain Research.
[28] H. Scheffé,et al. The Analysis of Variance , 1960 .
[29] F. Gage,et al. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis , 1986, Brain Research.
[30] C. Clough,et al. EMBRYOS AND PARKINSON'S DISEASE , 1988, The Lancet.
[31] E. Thorsby,et al. Antigens on Human Fibroblasts Demonstrated with HL‐A Antisera and Anti‐Human Lymphocytic Sera , 1968, Vox sanguinis.
[32] B J Hoffer,et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.
[33] R. Penn,et al. The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. , 1988, Neurosurgery.
[34] L. Olson,et al. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation , 1986, Neuroscience Letters.
[35] J C Rothwell,et al. The Bereitschaftspotential, L-DOPA and Parkinson's disease. , 1987, Electroencephalography and Clinical Neurophysiology.
[36] S. Haber,et al. Survival and growth of fetal catecholamine neurons transplanted into primate brain , 1986, Brain Research Bulletin.
[37] S. Haber,et al. FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINE , 1986, The Lancet.
[38] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[39] O. Lindvall,et al. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen , 1987, Annals of neurology.
[40] P. Nunn,et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.
[41] J. Peuler,et al. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.
[42] L. Molander,et al. MEMORY DISTURBANCES AFTER ELECTROCONVULSIVE THERAPY , 1957, Acta psychiatrica et neurologica Scandinavica.
[43] J. Powell,et al. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] F. Gage,et al. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cells implanted in different brain sites , 1983 .
[45] W. Freed,et al. Normalization of spiroperidol binding in the denervated rat striatum by homologous grafts of substantia nigra. , 1983, Science.
[46] Y. Naum,et al. Growth of Pulmonary Alveolar Macrophages in vitro , 1973, Nature.
[47] C. Nahmias,et al. Central Dopaminergic Pathways in Hemiparkinsonism Examined by Positron Emission Tomography , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[48] A. Björklund,et al. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing , 1980, Brain Research.
[49] J. D. Parkes,et al. Fluctuations of disability in Parkinson's disease – clinical aspects , 1981 .
[50] S. Hunt,et al. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1988, Progress in brain research.
[51] J. Langston,et al. 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra , 1984, Neuroscience Letters.
[52] R. Drucker-Colín,et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. , 1988, The New England journal of medicine.
[53] Voon Wee Yong,et al. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients , 1986, Neuroscience Letters.
[54] S. Kish,et al. Glutathione peroxidase activity in Parkinson's disease brain , 1985, Neuroscience Letters.
[55] F. Gage,et al. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. , 1983, Acta physiologica Scandinavica. Supplementum.
[56] P. A. Peterson,et al. Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. , 1984, Human immunology.
[57] B. J. Hopper,et al. FETAL DOPAMINE-RICH MESENCEPHALIC GRAFTS IN PARKINSON'S DISEASE , 1988, The Lancet.
[58] A. Barbeau,et al. Environmental and genetic factors in the etiology of Parkinson's disease. , 1987, Advances in neurology.
[59] A. Björklund,et al. Functional Activity of Substantia Nigra Grafts Reinnervating the Striatum: Neurotransmitter Metabolism and [14C]2‐Deoxy‐d‐glucose Autoradiography , 1982, Journal of neurochemistry.
[60] A. Björklund,et al. Functional reinnervation of the denervated neostriatum by nigral transplants , 1980, Peptides.
[61] A. Bjo¨rklund,et al. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival , 1985, Brain Research.